HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naresh Babu Kannan Selected Research

Sclerostomy

1/2022A report on a series of nanophthalmos with histopathology and immunohistochemistry analyses using light microscopy.
1/2021A comparative study on endothelial cell loss in nanophthalmic eyes undergoing cataract surgery by phacoemulsification.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naresh Babu Kannan Research Topics

Disease

6Endophthalmitis (Ophthalmia)
04/2022 - 01/2018
4Retinal Perforations
12/2023 - 10/2021
3Cataract (Cataracts)
01/2022 - 01/2021
2Coloboma (Colobomas)
04/2024 - 03/2020
2Inflammation (Inflammations)
01/2023 - 01/2022
2COVID-19
01/2022 - 11/2020
2Retinal Detachment (Retinal Detachments)
05/2021 - 03/2020
1Microphthalmos
04/2024
1Eye Diseases (Eye Disease)
12/2023
1Tuberculosis (Tuberculoses)
12/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2023
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
01/2022
1Retinopathy of Prematurity (Retrolental Fibroplasia)
07/2021
1Aphakia
05/2021
1Telangiectasis (Telangiectasia)
05/2021
1Infections
11/2020
1Hyperkalemia
05/2020
1Retinitis
04/2020
1Hamartoma
11/2019
1Tuberous Sclerosis (Bourneville's Disease)
11/2019
1Blindness (Hysterical Blindness)
10/2019

Drug/Important Bio-Agent (IBA)

3Retinaldehyde (Retinal)IBA
01/2022 - 11/2019
2SteroidsIBA
01/2022 - 10/2019
2Bevacizumab (Avastin)FDA Link
08/2021 - 01/2018
1MicroRNAs (MicroRNA)IBA
12/2023
1Biomarkers (Surrogate Marker)IBA
12/2023
1RNA (Ribonucleic Acid)IBA
12/2023
1Proteins (Proteins, Gene)FDA Link
01/2023
1ProteomeIBA
01/2023
1Amikacin (A.M.K)FDA LinkGeneric
04/2022
1mesoglycanIBA
01/2022
1Coloring Agents (Dyes)IBA
10/2021
1coomassie Brilliant BlueIBA
10/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2020
1closantelIBA
10/2019
1Endothelial Growth FactorsIBA
01/2018
1Ranibizumab (Lucentis)FDA Link
01/2018
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2018

Therapy/Procedure

5Vitrectomy
07/2021 - 03/2020
3Intravitreal Injections
08/2021 - 01/2018
2Intraocular Lenses (Intraocular Lens)
04/2024 - 05/2021
2Operative Surgical Procedures
04/2024 - 01/2022
2Therapeutics
01/2022 - 05/2020
2Sclerostomy
01/2022 - 01/2021
2Injections
08/2021 - 01/2018
2Vitreoretinal Surgery
05/2021 - 11/2020
1Solid-State Lasers
08/2022
1Anesthesia
01/2022
1Phacoemulsification
01/2021
1Light Coagulation
04/2020